147 related articles for article (PubMed ID: 14987857)
1. Synthesis and preliminary evaluation of the new water-soluble radioactive platinum(IV) complexes.
Garnuszek P; Maurin M; Skierski JS; Koronkiewicz M; Witowska-Jarosz J
J Inorg Biochem; 2004 Mar; 98(3):553-9. PubMed ID: 14987857
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model.
Garnuszek P; Karczmarczyk U; Maurin M
Nucl Med Biol; 2008 Jul; 35(5):605-13. PubMed ID: 18589305
[TBL] [Abstract][Full Text] [Related]
3. Radiochemical synthesis and preliminary in vivo evaluation of new radioactive platinum complexes with carnosine.
Maurin M; Garnuszek P
Appl Radiat Isot; 2010 Feb; 68(2):317-24. PubMed ID: 19939689
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
5. Marked survival prolongation of mice bearing a transplantable colon adenocarcinoma by treatment with radioactive platinum-[125I]histamine complex. Preliminary report.
Garnuszek P
Nucl Med Rev Cent East Eur; 2004; 7(2):113-6. PubMed ID: 15968596
[TBL] [Abstract][Full Text] [Related]
6. Biological investigation of the platinum(II)-[*I]iodohistamine complexes of potential synergistic anti-cancer activity.
Garnuszek P; Liciańska I; Skierski JS; Koronkiewicz M; Mirowski M; Wiercioch R; Mazurek AP
Nucl Med Biol; 2002 Feb; 29(2):169-75. PubMed ID: 11823121
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
Zhang J; Liu L; Gong Y; Zheng X; Yang M; Cui J; Shen S
Eur J Med Chem; 2009 May; 44(5):2322-7. PubMed ID: 18524422
[TBL] [Abstract][Full Text] [Related]
8. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
9. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
12. [Pt(HPxSC)Cl(3)], a novel platinum(IV) compound with anticancer properties.
Marković M; Knezević N; Momcilović M; Grgurić-Sipka S; Harhaji L; Trajković V; Mostarica Stojković M; Sabo T; Miljković D
Eur J Pharmacol; 2005 Jul; 517(1-2):28-34. PubMed ID: 15970285
[TBL] [Abstract][Full Text] [Related]
13. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
Desbois N; Gardette M; Papon J; Labarre P; Maisonial A; Auzeloux P; Lartigue C; Bouchon B; Debiton E; Blache Y; Chavignon O; Teulade JC; Maublant J; Madelmont JC; Moins N; Chezal JM
Bioorg Med Chem; 2008 Aug; 16(16):7671-90. PubMed ID: 18656367
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and DNA-binding levels of new type binuclear platinum(II) complexes.
Zhang J; Li Y; Sun J; Li W; Gong Y; Zheng X; Cui J; Wang R; Wu J
Eur J Med Chem; 2009 Nov; 44(11):4772-7. PubMed ID: 19615790
[TBL] [Abstract][Full Text] [Related]
17. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.
Drewa T; Olszewska-Słonina D; Woźniak A; Styczyński J; Drewa G; Szłyk E; Lakomska I; Kobe J; Czajkowski R
Acta Pol Pharm; 2004; 61(1):39-44. PubMed ID: 15259856
[TBL] [Abstract][Full Text] [Related]
18. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
Kim WK; Kwon YE
Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
[TBL] [Abstract][Full Text] [Related]
19. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
[TBL] [Abstract][Full Text] [Related]
20. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
